In this episode of the podcast, Co-directors of LBF, Nathan Cheng and Mark Hamalainen, interview Alexander Fedintsev, Chief Science Officer at RLE Group, to explore groundbreaking insights into ageing and longevity. Alexander delves into the intricate role of the extracellular matrix (ECM) and long-lived cells in the ageing process, sharing his journey into the field and his research on geroprotectors and ageing mechanisms. The conversation uncovers the complexity of ageing as an interconnected network, addressing programmed ageing and the challenges of repairing damage in non-dividing cells.
Key topics include the impact of ageing on the immune system, the exponential growth of clonal hematopoiesis, and the role of DNA mutations and mitochondria in ageing. Alexander highlights the potential of repairing the ECM for radical longevity, emphasizing the significance of elastin and potential approaches to ECM repair. The discussion also explores the potential of tissue replacement, particularly brain tissue, and the concept of cryopreservation, alongside its challenges and limitations.
The episode underscores the need for functional biomarkers of ageing and an engineering mindset in the field. It identifies bottlenecks in ageing research, including the lack of commercial viability and the need for funding and support for bioengineering approaches. The conversation concludes with an optimistic outlook on the rate of progress and the potential for achieving radical life extension in the near future.
Podden och tillhörande omslagsbild på den här sidan tillhör Longevity Biotech Fellowship. Innehållet i podden är skapat av Longevity Biotech Fellowship och inte av, eller tillsammans med, Poddtoppen.
